We are live on ! Find out more
RMD icon

ResMed
RMD

871 hedge funds and large institutions have $20.7B invested in ResMed in 2024 Q4 according to their latest regulatory filings, with 151 funds opening new positions, 333 increasing their positions, 265 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 151 | Existing positions closed: 68

26% more repeat investments, than reductions

Existing positions increased: 333 | Existing positions reduced: 265

9% more funds holding

Funds holding: 801 → 871 (+70)

2.27% more ownership

Funds ownership: 59.43% → 61.7% (+2.3%)

3% less capital invested

Capital invested by funds: $21.3B → $20.7B (-$587M)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

79% less call options, than puts

Call options by funds: $86.1M | Put options by funds: $416M

Holders
871
Holders Change
+70
Holders Change %
+8.74%
% of All Funds
11.47%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.11%
New
151
Increased
333
Reduced
265
Closed
68
Calls
$86.1M
Puts
$416M
Net Calls
-$330M
Net Calls Change
+$36.3M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$168M
2
Invesco
Invesco
Georgia
+$136M
3
Bank of America
Bank of America
North Carolina
+$110M
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$95.1M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$86.1M

Top Sellers

Rank Fund Capital Flow
1
GC
Greenvale Capital
United Kingdom
-$171M
2
Morgan Stanley
Morgan Stanley
New York
-$145M
3
Coatue Management
Coatue Management
New York
-$116M
4
Marshall Wace
Marshall Wace
United Kingdom
-$95.3M
5
Millennium Management
Millennium Management
New York
-$87.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWC
851
Spectrum Wealth Counsel
Indiana
$1.14K – – –
TFM
852
TFC Financial Management
Massachusetts
$1.14K – – –
NL
853
NVWM LLC
Pennsylvania
$1.14K – – –
HCP
854
Hexagon Capital Partners
Arkansas
$1.14K +$1.2K +5 New
SO
855
Sierra Ocean
California
$919 +$963 +4 New
EBA
856
Eagle Bay Advisors
New York
$915 -$1.45K -6 -60%
PWA
857
Physician Wealth Advisors
Utah
$915 +$963 +4 New
1IA
858
1620 Investment Advisors
Massachusetts
$883 – – –
T
859
Transce3nd
Texas
$693 +$722 +3 New
RS
860
Rakuten Securities
Japan
$686 – – –
CA
861
Continuum Advisory
Idaho
$457 – – –
CAC
862
Core Alternative Capital
Georgia
$457 – – –
JFG
863
JDM Financial Group
Texas
$457 – – –
WA
864
WestEnd Advisors
North Carolina
$457 – – –
WPA
865
West Paces Advisors
Georgia
$457 – – –
PWM
866
Parkworth Wealth Management
California
$457 +$482 +2 New
WA
867
WPG Advisers
Maryland
$457 +$482 +2 New
CA
868
CoreCap Advisors
Michigan
$229 -$8.43K -35 -97%
AA
869
Ancora Advisors
Ohio
$229 – – –
AWM
870
Activest Wealth Management
Florida
$229 +$241 +1 New
CAM
871
Chesapeake Asset Management
New York
$228 – – –
GC
872
Greenvale Capital
United Kingdom
– -$171M -700,000 Closed
Coatue Management
873
Coatue Management
New York
– -$116M -473,179 Closed
SPS
874
Susquehanna Portfolio Strategies
Pennsylvania
– -$26.2M -107,194 Closed
TI
875
Trexquant Investment
Connecticut
– -$25.8M -105,820 Closed
33 34
35
36 37

RMD Hedge Fund Activity: Q4 2024 in Review

871 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2024, worth a combined $20.7B — down 2.8% from $21.3B a quarter earlier.

Buyers outnumbered sellers: 151 funds opened new RMD positions and 68 closed out — a net gain of 83 holders — while 333 added to existing stakes and 265 trimmed.

The largest buyer was BlackRock, adding an estimated $168M. The largest seller was Greenvale Capital, exiting entirely with an estimated $171M sold.

  • 871 institutional investors held ResMed (RMD) as of Q4 2024, up from 801 in Q3 2024.
  • Funds reported $20.7B of ResMed stock for Q4 2024, down 2.8% quarter-over-quarter.
  • 151 funds opened new ResMed positions in Q4 2024 and 68 closed out, a net change of +83 holders.
  • The largest ResMed buyer in Q4 2024 was BlackRock, an estimated $168M added.
  • The largest ResMed seller in Q4 2024 was Greenvale Capital, an estimated $171M sold.

Based on aggregated 13F filings for Q4 2024.